
AAN 2026
Mayo Clinic Pilot Study Suggests Rimegepant May Benefit Some Cluster Headache Patients
A prospective open-label pilot study from Mayo Clinic presented at

A prospective open-label pilot study from Mayo Clinic presented at

In a packed session at the 2026 Annual Meeting of

Headache medicine is being quietly rewritten, and Liza Smirnoff, MD,

In a wide-ranging “Updates in Epilepsy” session delivered today at

Functional MRI study from Taipei and Mayo Clinic identifies locus

Investigators at Vanderbilt University Medical Center have reported preliminary validation